宣泰医药
(688247)
| 流通市值：48.64亿 | | | 总市值：48.64亿 |
| 流通股本：4.53亿 | | | 总股本：4.53亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 249,100,119.81 | 209,050,861.02 | 148,955,862.02 | 225,785,781.43 |
| 交易性金融资产 | 516,443,068.49 | 534,112,246.52 | 584,452,996.41 | 507,742,124.86 |
| 应收票据及应收账款 | 83,473,147 | 82,119,143.97 | 63,321,304.26 | 103,524,626.45 |
| 应收账款 | 83,473,147 | 82,119,143.97 | 63,321,304.26 | 103,524,626.45 |
| 预付款项 | 11,120,911.33 | 9,032,548.9 | 11,378,516.56 | 13,059,733.35 |
| 其他应收款合计 | 3,707,396.45 | 3,656,761.84 | 2,778,063.08 | 2,731,474.01 |
| 存货 | 90,169,385.2 | 100,712,763.05 | 102,397,398.38 | 102,418,450.82 |
| 合同资产 | 11,036,881.41 | 11,338,686.84 | 9,224,879.32 | 7,446,413.64 |
| 其他流动资产 | 8,184,765.54 | 8,014,403.87 | 60,780,066.96 | 13,609,284.63 |
| 流动资产合计 | 973,235,675.23 | 958,037,416.01 | 983,289,086.99 | 976,317,889.19 |
| 非流动资产: | | | | |
| 长期股权投资 | 65,792,803.07 | 65,141,985.16 | 64,405,714.41 | 64,416,376.31 |
| 固定资产 | 294,776,272.02 | 297,882,230.19 | 295,362,470.83 | 263,565,659.95 |
| 在建工程 | 63,986,228.99 | 61,111,701.01 | 61,538,657.62 | 80,754,194.31 |
| 使用权资产 | 37,189.73 | 53,128.19 | 9,931.07 | 24,827.63 |
| 无形资产 | 16,649,558.54 | 18,264,604.24 | 19,954,595 | 21,650,482.01 |
| 商誉 | 18,385,750.74 | 18,385,750.74 | 18,385,750.74 | 18,385,750.74 |
| 长期待摊费用 | 552,209.68 | 680,440.08 | 814,239.19 | 918,295.28 |
| 递延所得税资产 | 18,544,190.61 | 18,760,496.93 | 18,958,796.01 | 19,330,308.72 |
| 其他非流动资产 | 4,363,384.96 | 5,095,556.36 | 5,944,503.06 | 7,940,309.06 |
| 非流动资产合计 | 483,087,588.34 | 485,375,892.9 | 485,374,657.93 | 476,986,204.01 |
| 资产总计 | 1,456,323,263.57 | 1,443,413,308.91 | 1,468,663,744.92 | 1,453,304,093.2 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 20,641,748.04 | 21,875,107.81 | 27,611,574.16 | 20,667,815.65 |
| 应付账款 | 20,641,748.04 | 21,875,107.81 | 27,611,574.16 | 20,667,815.65 |
| 合同负债 | 28,488,342.55 | 30,216,454.39 | 37,821,685.35 | 30,440,121.14 |
| 应付职工薪酬 | 9,003,326.67 | 8,833,557.22 | 12,677,618.58 | 24,461,481.93 |
| 应交税费 | 4,324,314.21 | 2,443,683.52 | 7,318,260.49 | 8,881,873.55 |
| 其他应付款合计 | 16,260,911.4 | 7,495,747.63 | 13,325,292.89 | 16,503,119.26 |
| 应付股利 | 11,225,097.28 | - | 1,760,946.75 | 1,760,946.75 |
| 一年内到期的非流动负债 | 22,271.31 | 38,187.26 | 6,557.72 | 6,392.93 |
| 其他流动负债 | 948,421.7 | 1,265,608.91 | 2,261,503.76 | 2,225,845.46 |
| 流动负债合计 | 79,689,335.88 | 72,168,346.74 | 101,022,492.95 | 103,186,649.92 |
| 非流动负债: | | | | |
| 递延收益 | 66,364,934.98 | 67,614,014.86 | 71,791,502.21 | 74,719,106.5 |
| 递延所得税负债 | 2,286,560.86 | 2,322,201.15 | 2,356,102.91 | 2,393,999.02 |
| 非流动负债合计 | 68,651,495.84 | 69,936,216.01 | 74,147,605.12 | 77,113,105.52 |
| 负债合计 | 148,340,831.72 | 142,104,562.75 | 175,170,098.07 | 180,299,755.44 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 453,340,000 | 453,340,000 | 453,340,000 | 453,340,000 |
| 资本公积 | 512,937,672 | 512,902,400.27 | 513,570,870.69 | 513,570,870.69 |
| 减:库存股 | 36,126,025.26 | 36,126,025.26 | 36,126,025.26 | 36,126,025.26 |
| 其他综合收益 | -12,932.76 | 357.33 | - | - |
| 盈余公积 | 32,202,213.54 | 32,202,213.54 | 32,202,213.54 | 32,202,213.54 |
| 未分配利润 | 345,641,504.33 | 338,989,800.28 | 330,506,587.88 | 310,017,278.79 |
| 归属于母公司股东权益合计 | 1,307,982,431.85 | 1,301,308,746.16 | 1,293,493,646.85 | 1,273,004,337.76 |
| 股东权益合计 | 1,307,982,431.85 | 1,301,308,746.16 | 1,293,493,646.85 | 1,273,004,337.76 |
| 负债和股东权益合计 | 1,456,323,263.57 | 1,443,413,308.91 | 1,468,663,744.92 | 1,453,304,093.2 |
| 公告日期 | 2025-10-31 | 2025-08-23 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |